anifrolumab and oral deucravacitinib shows promise in patients with lupus
Published 1 year ago • 301 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
10:18
richard furie, md, talks about anifrolumab treatment in patients with sle
-
7:39
anifrolumab modulates key immune pathways in patients with systemic lupus erythematosus (sle)
-
8:58
astrazeneca - fda approval of saphnelo™ (anifrolumab) for lupus erythematosus (sle)
-
31:30
progress & promise: the future of lupus treatment
-
24:05
advances in treatment of lupus
-
3:25
top medical news 14.11.22
-
6:15
three new medications for lupus: dr. eric dein
-
17:34
rheumnow podcast – saphnelo (anifrolumab) approved for lupus (8.6.2021)
-
1:59
phase 2 trial of iberdomide in systemic lupus erythematosus | nejm
-
1:12
deucravacitinib at eular 2022
-
16:07
leibniz-inflammation lectures 2018 02 23 antigoni triantafyllopoulou
-
1:23
dupilumab improves sleep in atopic dermatitis, j.f. merola et al.
-
5:31
long-term persistence and effectiveness of il-12/23 pathway inhibitor ustekinumab and tnf inhibitors
-
3:43
atherosclerosis and lupus
-
14:36
finals anaes saq30: phaeochromocytoma
-
3:56
current unmet needs in lupus treatment with dr. rich furie
-
2:53
dsp mutations and arrhythmogenic cardiomyopathy, t. maruthappu et al.
-
2:00
dr. richard furie - anifrolumabs impressive results in lupus
-
2:01:31
lupus nephritis 2